Themis Medicare Ltd
Themis Medicare Ltd (THEMISMED) last traded at ₹119, a market capitalisation of ₹1,096 crore. Over the past 52 weeks the stock has ranged between ₹65 and ₹148. Themis Medicare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹87 crore and net profit of ₹25 crore. Figures are as of 25 Aug 2026 and are not real time.
Themis Medicare Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Themis Medicare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹87 cr, down 11.2% from ₹98 cr a year earlier. Net profit turned positive at ₹25 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 117 | 94 | 72 | 98 | 78 | 90 | 77 | 87 |
| Expenses | 100 | 88 | 79 | 108 | 81 | 80 | 73 | 139 |
| Operating profit | 17 | 6 | -8 | -10 | -3 | 10 | 4 | -52 |
| OPM % | 15% | 6% | -11% | -10% | -4.0% | 11% | 4.9% | -60% |
| Other income | 6 | 1 | 2 | 1 | 5 | 6 | 11 | 97 |
| Interest | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 18 | 2 | -11 | -14 | -3 | 10 | 9 | 39 |
| Tax % | 20% | 69% | -13% | 1% | 5% | 3% | 2% | 36% |
| Net profit | 14 | 1 | -10 | -14 | -4 | 10 | 9 | 25 |
| EPS (₹) | 1.55 | 0.06 | -1.05 | -1.54 | -0.39 | 1.10 | 0.97 | 2.67 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Themis Medicare Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 231 | 395 | 354 | 382 | 406 | 342 | 332 |
| Operating profit | 49 | 96 | 67 | 52 | 49 | 0 | -42 |
| OPM % | 21% | 24% | 19% | 13% | 12% | 0.1% | -13% |
| Net profit | 36 | 73 | 57 | 44 | 30 | 1 | 40 |
| EPS (₹) | 3.88 | 7.92 | 6.18 | 4.73 | 3.24 | 0.12 | 4.35 |
TTM is the trailing twelve months to the most recent quarter.
Themis Medicare Ltd growth and returns
- 10 Years
- 4%
- 5 Years
- 8%
- 3 Years
- -1%
- TTM
- -13%
- 10 Years
- -20%
- 5 Years
- -46%
- 3 Years
- -69%
- TTM
- -321%
- 10 Years
- 8%
- 5 Years
- 2%
- 3 Years
- -9%
- 1 Year
- 19%
- 10 Years
- 11%
- 5 Years
- 12%
- 3 Years
- 6%
- Last Year
- 0%
Themis Medicare Ltd shareholding pattern
Promoters held 67.10% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.01% and DIIs 0.01%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.15% | 67.15% | 67.15% | 67.15% | 67.15% | 67.10% | 67.10% | 67.10% |
| FIIs | 0.10% | 0.10% | 0.14% | 0.09% | 0.06% | 0.05% | 0.11% | 0.01% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 32.74% | 32.75% | 32.70% | 32.75% | 32.77% | 32.84% | 32.78% | 32.87% |
| No. of shareholders | 14,270 | 17,773 | 17,889 | 19,335 | 22,490 | 22,576 | 21,818 | 21,267 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Themis Medicare Ltd corporate filings
- Announcements Under Regulation 30 (LODR)- Change Of Company Secretary / Compliance Officer''s E-Mail ID And Updation Of E-Mail Id Of RTA,Company Updatelow impact
Cruxal's analysis: Themis Medicare Ltd has issued a routine regulatory filing under Regulation 30 of the…
Read the full analysis - Newspaper Publication of Un-audited Financial Results for the quarter ended 30th June, 2026Company Updatelow impact
Cruxal's analysis: Themis Medicare Limited has released its unaudited standalone and consolidated financial…
Read the full analysis - Investors Presentation for the quarter ended 30.06.2026Company Updatemedium impact
Cruxal's analysis: Themis Medicare Limited reported Q1 FY27 consolidated revenue of 86.96 crore, a 10.9%…
Read the full analysis - Announcement Under Regulation 30(5) Of SEBI (LODR)- UpdatesCompany Updatelow impact
Cruxal's analysis: Themis Medicare Ltd has submitted a routine disclosure under Regulation 30(5) of the SEBI…
Read the full analysis - Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2026.Board Meetinghigh impact
Cruxal's analysis: Themis Medicare Limited reported standalone net profit of 28.74 crore for the quarter…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Themis Medicare Limited has reported that the Vividhmargi Trust has pledged an additional…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Themis Medicare Ltd
Cruxal reads every Themis Medicare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.